Dublin, Feb. 28, 2019 (GLOBE NEWSWIRE) -- The "Proteomics Market by Instrument (Spectroscopy, Chromatography, Electrophoresis, Microfluidics, X-ray Crystallography), Reagents, Services & Software (Protein Identification, Characterization, Bioinformatics), Application - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The proteomics market is projected to reach USD 38.7 billion by 2024 from USD 19.5 billion in 2019, at a CAGR of 14.7%.
An increase in the research activity, especially in the area of personalized medicine and drug discovery is the primary growth driver for this market. In addition, the increasing R&D expenditure by pharmaceutical and biotechnology companies, increasing government funding, and technological advancements are also propelling the growth of the proteomics market.
The growing prominence of nanoproteomics and personalized proteomics for precision health offers significant growth opportunities for players in this market. However, low biomarker discovery-to-approval ratio and data management in proteomics research are some of the major market challenges.
The protein fractionation segment is expected to grow at the highest rate during the forecast period
Based on instrumentation technology, the proteomics market is segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, and protein fractionation. The protein fractionation segment is projected to witness the highest growth in the proteomics market during the forecast period.
This growth is attributed to the benefits of protein fractionation, such as its ability to effectively separate thousands of proteins in a complex structure. The need for the analysis of complex mixtures comprising proteins is increasing in proteomics research; this serves to drive the market demand for protein fractionation systems.
The bioinformatics software & services segment is expected to grow at the highest CAGR during the forecast period
Based on services and software, the proteomics market is segmented into core proteomics services and bioinformatics software & services. The bioinformatics software & services segment is projected to witness the highest growth rate during the forecast period.
With the exponential growth in the determination of protein sequences and structures via genome sequencing and structural genomics efforts, there is a growing need for reliable computational methods to determine the biochemical function of these proteins. This is expected to drive the growth of the bioinformatics segment in the coming years.
APAC is projected to witness the highest growth during the forecast period.
Even though North America is expected to account for the largest share of the global proteomics market in 2018, APAC is expected to witness the highest CAGR during the forecast period.
The growing Asian scientific base and capability, growing proteomics and genomics research and increasing research funding, increasing investments by pharmaceutical and biotechnology companies, growing awareness about personalized therapeutics, and increasing research activities in the field of mAb-based therapeutics are factors driving the growth of this regional segment.
Topics Covered
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Stakeholders
1.6 Limitations
2 Research Methodology
2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Break Down of Primaries
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Proteomics: Market Overview
4.2 Proteomics Market: Geographic Growth Opportunities
4.3 Regional Mix: Proteomics Market (2019-2024)
4.4 Proteomics Market: Developed vs Developing Markets, 2019 vs 2024
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Demand for Personalized Medicine
5.2.1.2 Proteomics Bridges the Gap Between Genomics and Biochemistry
5.2.1.3 Increasing Pharmaceutical and Biotechnology R&D Expenditure and Government Funding for Proteomics
5.2.1.4 Technological Advancements
5.2.2 Market Restraints
5.2.2.1 High Cost of Instruments
5.2.3 Market Opportunities
5.2.3.1 Growing Prominence of Nanoproteomics - The Convergence of Nanotechnology & Proteomics
5.2.3.2 Personalized Proteomics for Precision Health
5.2.3.3 High Growth Opportunities in Emerging Countries
5.2.4 Market Challenges
5.2.4.1 Data Management in Proteomics Research
5.2.4.2 Low Biomarker Discovery-To-Approval Ratio
6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Integration of Omics Data in Biomedical Sciences
6.2.2 Growing Focus on Monitoring Post-Translational Modifications
6.2.3 Increasing Uptake of Label-Free Quantification Techniques
6.2.4 Integrating Networks and Proteomics
6.3 Unmet Needs Analysis
6.3.1 Challenges in Analyzing Low Abundance Proteins
7 Proteomics Market, By Instrumentation Technology
7.1 Introduction
7.2 Spectroscopy
7.2.1 Mass Spectroscopy
7.2.1.1 The Ability of Ms to Identify Small Amounts of Protein From Increasingly Complex Mixtures is A Major Factor Driving Its Use in Proteomics
7.2.2 NMR Spectroscopy
7.2.2.1 NMR Experiments Used to Evaluate the Physical, Chemical, Electronic, and Structural Information of Proteins
7.2.3 CD Spectroscopy
7.2.3.1 CD Spectroscopy is Used to Examine Changes in Secondary Structures of Protein in Response to Environmental Conditions Or Interactions With Other Molecules
7.3 Chromatography
7.3.1 HPLC
7.3.1.1 The Two Types of HPLC Systems Commonly Available in the Market are Split Flow Systems and Non-Split Flow Systems
7.3.2 Ion Chromatography
7.3.2.1 Ion Chromatography is the Most Commonly Used Chromatographic Method for Separating Proteins, Polypeptides, Nucleic Acids, and Other Charged Molecules
7.3.3 Affinity Chromatography
7.3.3.1 Affinity Chromatography Can Be Used in Two Ways, Either Through the Enrichment of A Specific Class of Proteins Or Depletion of Certain Types of Proteins
7.3.4 Supercritical Fluid Chromatography
7.3.4.1 Sfc and Mass Spectrometry are Used for the Separation and Analysis of Integral Membrane Proteins and Hydrophobic Peptides
7.4 Electrophoresis
7.4.1 Gel Electrophoresis
7.4.1.1 The Most Common Use of Gel Electrophoresis is the Qualitative Analysis of A Complex Mixture of Proteins
7.4.2 Capillary Electrophoresis
7.4.2.1 Ce Coupled With Ms is Used to Assess the Structure and Identity of Individual Proteins, Including Intact Proteins Over A Wide Molecular Weight Range
7.5 Protein Microarrays
7.5.1 Biochips
7.5.1.1 Lab-On-Chips (Microfluidics)
7.5.1.1.1 Loc is One of the Fastest Growing Areas of Microfabrication and Nanotechnology Development
7.5.1.2 Protein Chips
7.5.1.2.1 The Automated, Affordable, and Highly Sensitive Solutions Offered By Protein Chips Give Them A Advantage Over Conventional Protein Analysis Tools
7.5.2 Microarray Instruments
7.5.2.1 Integrated Systems
7.5.2.1.1 Integrated Systems are Capable of Carrying Out the Entire Procedure of Protein Analysis Without Any Intermediate Steps
7.5.2.2 Microarray Scanners
7.5.2.2.1 Microarray Scanners Find Applications in the Data Analysis of Proteins, Tissues, and Cells
7.5.2.3 Arrayers
7.5.2.3.1 Technological Advancements Have Made Microarray Spotters Ideal for Large-Scale Arraying Projects
7.6 X-Ray Crystallography
7.6.1 X-Ray Crystallography Helps in the Measurement of the 3D Density Distribution of Electrons in A Crystallized Protein in A Certain Resolution
7.7 Surface Plasmon Resonance
7.7.1 Spr Imaging Helps Monitor A Range of Molecular Interactions, Such as Peptide-Protein, Carbohydrate-Protein, Protein-Protein Binding, and Surface Enzyme Kinetics
7.8 Protein Fractionation
7.8.1 Protein Fractionation Refers to the Process of Isolating, Identifying, and Characterizing Various Proteins in A Sample of Complex Proteome Mixtures
8 Proteomics Market, By Reagent
8.1 Introduction
8.2 Immunoassay Reagents
8.2.1 Immunoassay Reagents to Dominate the Market During the Forecast Period
8.3 Spectroscopy Reagents
8.3.1 The Use of These Reagents is Increasing With the Rising Adoption of Ms Techniques
8.4 Chromatography Reagents
8.4.1 Increasing Demand for Protein Purification is Expected to Drive Market Growth
8.5 Protein Microarray Reagents
8.5.1 Use of These Reagents has Increased for Analyzing Protein Interactions
8.6 X-Ray Crystallography Reagents
8.6.1 Study of Protein Structural Orientation Forms a Part of Crystallography Study
8.7 Electrophoresis Reagents
8.7.1 Increasing Demand for 2d Electrophoresis is Driving the Adoption of These Reagents
8.8 Protein Fractionation Reagents
8.8.1 Increasing Protein Separation From Complex Mixtures Makes This One of the Fastest-Growing Segments
9 Proteomics Market, By Services & Software
9.1 Introduction
9.2 Core Proteomics Services
9.2.1 Protein Identification Services
9.2.1.1 Protein Identification Services to Dominate the Market During the Forecast Period
9.2.2 Protein Characterization Services
9.2.2.1 Characterization Studies Play A Vital Role in Studying Complex Protein Structure, Drug Development, and PTMS
9.2.3 Quantitative Proteomics Services
9.2.3.1 Quantitative Proteomics is Critical for Understanding Protein Expression and Modifications
9.2.4 Protein Purification Services
9.2.4.1 Protein Purification AIDS in Improving the Overall Proteome Analysis and Depends on the Probable Use of the Protein
9.2.5 Protein Separation Services
9.2.5.1 Separation Plays an Important Role in the Characterization of Large-Sized Proteomes
9.2.6 Protein Sequencing Services
9.2.6.1 Identification and Characterization of PTMS is an Important Area of Research That Needs Protein Sequencing
9.2.7 Custom Assay Services
9.2.7.1 Assays are Adopted to Improve the Validation Or Consistency of the Protein Analysis Procedures
9.3 Bioinformatics Software & Services
9.3.1 Bioinformatics Services
9.3.1.1 Bioinformatics Services are Set to Dominate the Market During the Forecast Period
9.3.2 Bioinformatics Tools
9.3.2.1 Need for Data Management and Quality Enhancement of Results Obtained Makes Tools an Imperative Part of Proteomics
9.3.3 Bioinformatics Databases
9.3.3.1 Databases Majorly Contribute to Storing Proteomics Data Along With Integrating Other Omics Databases
10 Proteomics Market, By Application
10.1 Introduction
10.2 Clinical Diagnostics
10.2.1 Clinical Diagnostics is the Largest Application Segment of the Proteomics Market
10.3 Drug Discovery
10.3.1 Drug Discovery Applications to Register the Highest Growth in the Forecast Period
10.4 Other Applications
11 Proteomics Market, By Region
11.1 Introduction
11.2 North America
11.2.1 US
11.2.1.1 US Dominates the North American Proteomics Market
11.2.2 Canada
11.2.2.1 Strong Infrastructure and Availability of Funding for Biomedical Research Will Support Market Growth
11.3 Europe
11.3.1 Germany
11.3.1.1 Germany Holds the Largest Share of the European Market
11.3.2 UK
11.3.2.1 The UK has Seen A Surge in the Prevalence of Cancer and Neurological Disorders
11.3.3 France
11.3.3.1 Proteomics Research in France is Strongly Supported By the Government
11.3.4 Switzerland
11.3.4.1 Market Growth is Primarily Driven By the Well-Established Pharmaceutical & Biotechnology Industry in the Country
11.3.5 Italy
11.3.5.1 Growth in This Market is Mainly Driven By Increasing Life Science R&D in the Country, Funded By Both Public and Private Organizations
11.3.6 Spain
11.3.6.1 Spain has A Well-Established Network of Research Centers, Universities, and Hospitals, Which Form an Ideal Environment for Translational Medicine Research
11.3.7 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.1.1 Growth in R&D to Enhance the Technological Capabilities in the Country, Thereby Driving the Demand for High-Quality Research Tools
11.4.2 Japan
11.4.2.1 Large Number of Research Initiatives Towards the Development of Precision Medicine Supporting Market Growth in Japan
11.4.3 India
11.4.3.1 Increasing Pharma R&D and Government Funding in the Biotechnology Industry are the Major Factors Driving Market Growth in India
11.4.4 Australia
11.4.4.1 The Increasing Focus of the Healthcare System on Precision Medicine to Offer Significant Growth Opportunities in Australia
11.4.5 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.1.1 Research Being Undertaken in the Fields of Neuroscience, Inflammatory Diseases, and Drug Discovery, Among Other Fields to Drive Market Growth in Brazil
11.5.2 Mexico
11.5.2.1 Strong Pharmaceutical Industry in the Country to Provide Significant Growth Opportunities in Mexico
11.5.3 Rest of Latin America
11.6 Middle East & Africa
11.6.1 Increasing Partnerships Among Global Players With Government Organizations in the Region to Support Growth of Proteomics Research in the Middle East and Africa
12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Leadership Mapping
12.3.1 Visionary Leaders
12.3.2 Innovators
12.3.3 Dynamic Differentiators
12.3.4 Emerging Companies
12.4 Competitive Situation and Trends
12.4.1 Product & Services Launches
12.4.2 Expansions
12.4.3 Acquisitions
12.4.4 Other Strategies
13 Company Profiles
13.1 Thermo Fisher Scientific Inc.
13.2 Agilent Technologies Inc.
13.3 Merck KGaA
13.4 Danaher Corporation
13.5 Waters Corporation
13.6 Bio-Rad Laboratories Inc.
13.7 Bruker Corporation
13.8 GE Healthcare
13.9 Perkinelmer Inc.
13.10 Luminex Corporation
13.11 Creative Proteomics
13.12 Promega Corporation
For more information about this report visit https://www.researchandmarkets.com/research/gspt92/global_proteomics?w=12